Showing latest transactions and SEC Form 4 filings for KURA.
16 results.
| X | Filing Date | Trade Date | Ticker | Company Name | Insider Name | Title | Trade Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A M | 2026-11-17 16:05:06 | 2026-11-16 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | President and CEO, Director | P - Purchase | $7.52 | +200,000 | 1,992,725 | +5% | +$1,504,765 |
| M | 2026-11-16 19:45:03 | 2026-11-16 | KURA | Kura Oncology, Inc. | WILSON TROY EDWARD | President and CEO, Director | P - Purchase | $7.52 | +200,000 | 1,948,987 | +5% | +$1,504,765 |
| 2026-09-29 18:30:09 | 2026-09-28 | KURA | Kura Oncology, Inc. | Bair Teresa Brophy | Chief Legal Officer | S - Sale | $10.50 | -8,442 | 187,002 | -4% | -$88,618 | |
| M | 2026-09-29 18:30:07 | 2026-09-29 | KURA | Kura Oncology, Inc. | FORD KATHLEEN | Chief Operating Officer | S - Sale | $10.59 | -10,574 | 289,640 | -1% | -$111,931 |
| M | 2026-09-29 18:30:06 | 2026-09-29 | KURA | Kura Oncology, Inc. | Leoni Mollie | Chief Medical Officer | S - Sale | $10.67 | -41,250 | 310,992 | -8% | -$440,237 |
| 2026-09-29 18:30:04 | 2026-09-28 | KURA | Kura Oncology, Inc. | DOYLE THOMAS JAMES | SVP, Finance & Accounting | S - Sale | $10.50 | -4,607 | 142,928 | -3% | -$48,361 | |
| M | 2026-09-29 18:30:03 | 2026-09-29 | KURA | Kura Oncology, Inc. | Powl Brian T. | Chief Commercial Officer | S - Sale | $10.63 | -32,450 | 449,317 | -3% | -$345,036 |
| D | 2026-09-25 16:05:07 | 2026-09-24 | KURA | Kura Oncology, Inc. | Burrows Francis | Chief Scientific Officer | M - OptEx | $3.08 | +60,000 | 105,380 | 0% | +$184,500 |
| D | 2026-09-25 16:05:07 | 2026-09-24 | KURA | Kura Oncology, Inc. | Burrows Francis | Chief Scientific Officer | S - Sale+OE | $10.83 | -20,726 | 105,380 | -16% | -$224,514 |